Proteasome Inhibitors

Aug 27, 2016 by in ONCOLOGY Comments Off on Proteasome Inhibitors

Proteasome Inhibitors Christopher J. Kirk Brian B. Tuch Shirin Arastu-Kapur Lawrence H. Boise BIOCHEMISTRY OF THE UBIQUITIN-PROTEASOME PATHWAY The ubiquitin proteasome system is involved in the degradation of more than…

read more

Kinase Inhibitors as Anticancer Drugs

Aug 27, 2016 by in ONCOLOGY Comments Off on Kinase Inhibitors as Anticancer Drugs

Kinase Inhibitors as Anticancer Drugs Charles L. Sawyers INTRODUCTION In 2001, the first tyrosine-kinase inhibitor imatinib was approved for clinical use in chronic myeloid leukemia. The spectacular success of this…

read more

Antimicrotubule Agents

Aug 27, 2016 by in ONCOLOGY Comments Off on Antimicrotubule Agents

Antimicrotubule Agents Christopher J. Hoimes Lyndsay N. Harris MICROTUBULES Microtubules are vital and dynamic cytoskeletal polymers that play a critical role in cell division, signaling, vesicle transport, shape, and polarity,…

read more

Topoisomerase Interactive Agents

Aug 27, 2016 by in ONCOLOGY Comments Off on Topoisomerase Interactive Agents

Topoisomerase Interactive Agents Khanh T. Do Shivaani Kummar James H. Doroshow Yves Pommier CLASSIFICATION, BIOCHEMICAL, AND BIOLOGIC FUNCTIONS OF TOPOISOMERASES Nucleic acids (DNA and RNA) being long polymers, topoisomerases fulfill…

read more

Antimetabolites

Aug 27, 2016 by in ONCOLOGY Comments Off on Antimetabolites

Antimetabolites M. Wasif Saif Edward Chu ANTIFOLATES Reduced folates play a key role in one-carbon metabolism, and they are essential for the biosynthesis of purines, thymidylate, and protein biosynthesis. Aminopterin…

read more

Platinum Analogs

Aug 27, 2016 by in ONCOLOGY Comments Off on Platinum Analogs

Platinum Analogs Peter J. O’Dwyer A. Hilary Calvert INTRODUCTION The platinum drugs represent a unique and important class of antitumor compounds. Alone or in combination with other chemotherapeutic agents, cis-diamminedichloroplatinum…

read more

Alkylating Agents

Aug 27, 2016 by in ONCOLOGY Comments Off on Alkylating Agents

Alkylating Agents Kenneth D. Tew PERSPECTIVES Alkylating agents were the first anticancer molecules developed, and they are still used today. After more than 50 years of use, the basic chemistry…

read more

Pharmacogenomics

Aug 27, 2016 by in ONCOLOGY Comments Off on Pharmacogenomics

Pharmacogenomics Christine M. Walko Howard L. McLeod INTRODUCTION The evolution of understanding cancer biology has yielded many advances that have been translated into cancer treatment. Application of this knowledge has…

read more

Pharmacokinetics and Pharmacodynamics of Anticancer Drugs

Aug 27, 2016 by in ONCOLOGY Comments Off on Pharmacokinetics and Pharmacodynamics of Anticancer Drugs

Pharmacokinetics and Pharmacodynamics of Anticancer Drugs Alex Sparreboom Sharyn D. Baker INTRODUCTION Drug selection and therapy considerations in oncology were originally solely based on observations of the effects produced.1 To…

read more
Get Clinical Tree app for offline access